Skip to main content

Advertisement

SpringerLink
Log in

Quantitative analysis of thymosin α1 in human serum by LC-MS/MS

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

1bstract

1 high performance liquid chromatography with tandem mass spectrometry (LC-MS/MS) method was developed to measure the thymosin alpha 1 (Tα1) concentration in human serum. Tα1 in human serum was determined by solid phase extraction and reverse phase LC-MS/MS. The high-performance liquid chromatography (HPLC) system interfaced with the MS/MS system with a Turbo Ion spray interface. Positive ion detection and multiple reaction monitoring (MRM) mode were used for this human serum quantitation. Eight different concentration standards were used to establish the detection range. Six quality control (QC) and 2 matrix blanks were checked by calibration curves performed on the same day. The lower quantitation limit was 0.5 ng/mL T α1 in human serum. Calibration curves were established between 0.5 to 100 ng/mL by weighted linear regression. The correlation coefficients for different days were 0.9955 or greater. Quantitation of Tα1 by the LC-MS/MS method is fast accurate, and precise.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mutchnick MG, Appelman HD, Chung HT, et al. Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial.Hepatology: 1991:14:409–415.

    Article  CAS  PubMed  Google Scholar 

  2. Chien RN, Liaw YF, Chen TC, Yeh CT, Sheen IS. Efficacy of thymosin alphal in patients with chronic hepatitis B: A randomized, controlled trial.Hepatology. 1998;27:1383–1387.

    Article  CAS  PubMed  Google Scholar 

  3. Andreone P, Cursaro C, Gramenzi A, et al. A randomized controlled trial of thymosin alpha 1 versus interferon alpha treatment in patients with hepatitis B e antigen antibody- and hepatitis B virus DNA—positive chronic hepatitis B.Hepatology. 1996;24:774–777.

    CAS  PubMed  Google Scholar 

  4. Sherman KE, Sjogren M, Creager RL, et al. Combination therapy with thymosin alphal and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial.Hepatology. 1998;27:1128–1135.

    Article  CAS  PubMed  Google Scholar 

  5. Rasi G, DiVirgilio D, Mutchinick MG, et al. Combination thymosin al and lymphoblastoid interferon treatment in chronic hepatitis C.Gut. 1996;39:670–683.

    Article  Google Scholar 

  6. Moscarella S, Buzzelli G, Monti M, et al. Treatment with interferon-alpha and thymosin alpha 1 of naive patients affected by chronic hepatitis C.4th International Meeting on Hepatitis C Virus and Related Viruses. Kyoto, Japan, 1997.

  7. Garaci E, Rocchi G, Perroni L. et al. Combined therapy with zidovudine-thymosin alpha 1-alpha interferon in the treatment of HIV-infected patients.Second International Symposium on Combination Therapies, Sicily, Italy, 1992.

  8. Garaci E, Milanese G, Vella S, et al. A randomized controlled study for the evaluation of the activity of a triple combination of zidovudine, thymosin alpha 1 and interferon alpha in HIV-infected individuals with CD4 counts between 200 and 500 cells mm3.Antiviral Therapy. 1998;3:103–111.

    CAS  Google Scholar 

  9. Gravenstein S, Ershler WB, Drumaskin S, Schwab R, Weksler ME. Anti-influenze antibody response: augmentation in elderly “non-responders” by thymosin alpha 1. Gerontologist. 1986;26:150A.

    Article  Google Scholar 

  10. Gravenstein S, Duthie EH, Miller BA, et al. Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study.J Am Geriatr Soc. 1989;37:1–8.

    CAS  PubMed  Google Scholar 

  11. McConnell L, Gravenstein S, Roecker E, Spencer S, Simon G, Erschler W. Augmentation of influenza antibody levels and reduction in attack rates in elderly subjects by thymosin alpha 1.The Gerentologist. 1989;29:188A.

    Google Scholar 

  12. Lopez M, Di Lauro L, Vici P. et al. Biological agents and chemotherapy in the treatment of solid tumors, Third International Symposium on Combination Therapies, Houston, Texas. 1993. Institute for Advanced Studies in Immunology & Aging.

  13. Lopez M, Carpano S, Cavaliere R, DiLauro L, Ameglio F, Vitelli G. Biochemotherapy with thymosin alpha 1. interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects.Annals of Oncology. 1994;5:741–746.

    CAS  PubMed  Google Scholar 

  14. Sztein M, Serrate S. Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes.Int J Immunopharmacol. 1989;11:789–800.

    Article  CAS  PubMed  Google Scholar 

  15. Serrate S, Schulof R, Leondaridis L, Goldstein AL, Sztein MB. Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones.J Immunol. 1987;139:2338–2343.

    CAS  PubMed  Google Scholar 

  16. Di Francesco P, Pica F, Gaziano R, Favalli C, Garaci E. In vivo recovery of natural killer cell activity by the association of thymosin a 1 and cytokines during cocaine administation.Medical Science Research. 1994;22:41–42.

    Google Scholar 

  17. Favalli C, Mastino A, Jezzi T, Grelli S, Goldstein AL, Garaci E. Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice.Int J Immunopharmacol. 1989;11:443–450.

    Article  CAS  PubMed  Google Scholar 

  18. Ershler W, Moore A, Socinski M. Influenza and aging: age-related changes and the effects of thymosin on the antibody response to influenza vaccine.J Clin Immunol. 1984;4:445–454.

    Article  CAS  PubMed  Google Scholar 

  19. Effros RB, Casillas A, Walford RL. The effect of thymosin alpha 1 on immunity to influenza in aged mice. Aging: Immunology and Infectious Disease. Vol. 1: Mary Ann Liebert, Inc. New York, New York 1988: 31–40.

    Google Scholar 

  20. Baumann CA, Badamchian M, Goldstein AL. Thymosin alpha 1 antagonizes dexamethasone and CD3-induced apoptosis of CD4+CD8+ thymocytes through the activation of cAMP and protein kinase C dependent second messenger pathways.Mech Ageing Dev. 1997; 94:85–101.

    Article  CAS  PubMed  Google Scholar 

  21. Knutsen AP, Freeman JJ, Mueller KR, Roodman ST, Bouhasin JD. Thymosin-alphal stimulates maturation of CD34+ stem cells into CD3+4+ cells in an in vitro thymic epithelia organ coculture model [In Process Citation].Int J Immunopharmacol. 1999;21:15–26.

    Article  CAS  PubMed  Google Scholar 

  22. Goldstein A, Low T, Thurman G, et al. Current status of thymosin and other hormones of the thymus gland. Recent Prog Horm Res. 1981;37:369–415.

    CAS  PubMed  Google Scholar 

  23. Low TLK, Thurman GB, McAdoo M, et al. The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha 1 and polypeptide beta 1 from calf thymus.J Biol Chem. 1979;254:981–986.

    CAS  PubMed  Google Scholar 

  24. Low T, McClure J, Rossio J, Naylor P, Spangelo B, Goldstein A. Isolation of thymosin alpha 1 from thymosin fraction 5 of different species by high performance liquid chromatography.J Chromatogr. 1983;266:533–544.

    Article  CAS  PubMed  Google Scholar 

  25. Low T, Thurman G, Chincarini C, et al. Current status of thymosin research: Evidence for the existence of a family of thymic factors that control T-cell maturation.Ann N Y Acad Sci. 1979;332:33–48.

    Article  CAS  PubMed  Google Scholar 

  26. Oates K, Erdos M. Biochemical identification of thymosin alpha-1: its phylogenetic distribution and evolutionary implications.Comp Biochem Physiol. 1989;94-B:759–763.

    Google Scholar 

  27. Weller FE, Shah U, Cummings GD, Chretien PB, Mutchnick MG. Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adults.Thymus. 1992;19:45–52.

    CAS  PubMed  Google Scholar 

  28. Sherman K, Jones C, Goldstein A, Naylor P. Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus.Viral Immunol. 1991;4:195–199.

    Article  CAS  PubMed  Google Scholar 

  29. Welch R, Mutchnick M, Welter F, Sokol R. Maternal and fetal circulating levels of thymosin alpha 1 during parturition.Am J Reprod Immunol Microbiol. 1987;13:125–127.

    CAS  PubMed  Google Scholar 

  30. Welch R, Lee H, Sokol R, Mutchnick M. Amniotic fluid thymosin alpha 1 levels increase during gestation.Am J Reprod Immunol Microbiol. 1988;17:96–97.

    CAS  PubMed  Google Scholar 

  31. Rost K, Wierich W, Masayuki F, Tuthill C, Horwitz D, Hermann W. Pharmacokinetics of thymosin alpha 1 after subcutaneous injection of three different formulations in healthy volunteers.International Journal of Clinical Pharmacology and Therapeutics. 1999;37:51–57.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. SeiClone Pharmaceuticals, Inc., 901 Mariner's Island Blvd., 94404-1593, San Mateo, CA

    Cynthia W. Tuthill (Vice President Scientific Affairs) & Alfred Rudolph

  2. Ricerca. Inc., 7528 Auburn Road, 44077, Painesville, OH

    Yang Li, Beijing Tan, Thomas J. Fitzgerald, Stephen R. Beck & Yong-Xi Li

Authors
  1. Cynthia W. Tuthill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alfred Rudolph
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Beijing Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas J. Fitzgerald
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stephen R. Beck
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yong-Xi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cynthia W. Tuthill.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tuthill, C.W., Rudolph, A., Li, Y. et al. Quantitative analysis of thymosin α1 in human serum by LC-MS/MS. AAPS PharmSciTech 1, 11 (2000). https://doi.org/10.1208/pt010211

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/pt010211

Keywords

Search

Navigation